Researchers from @CedarsSinai examined the effects of immortalized cardiosphere-derived #extracellularvesicles in rats with heart failure with preserved ejection fraction. https://t.co/VgXROUjK6D
Our latest work on TBX18 Biological Pacemaker using mRNA technology - new ways to improve mRNA - based therapy @CedarsSinaiMed@CedarsSinai@EPeeps#Biopacer#mRNA#CRM
MicroRNA-dependent suppression of biological pacemaker activity induced by TBX18 https://t.co/yXzeuH5cwT
ARTICLE ALERT💡
Happy to share our recent article @JPhysiol "Reversal of right ventricular pressure loading improves function independent of fibrosis"🫀 I want to thank @RishiKTrivedi for your help and empathy and contributors🔬 @CedarsSinai
https://t.co/XXootmbXbv
Come join us #AHA22 for Novel Experimental Approaches in Arrhythmias. @jaechomdphd is presenting the anti-arrhythmic effects of exosomes derived from CDCs in HFpEF animal model.
@CedarsSinaiMed@MarbanLab
Join us 3:30pm for two amazing back-to-back basic research sessions at #AHA22#cardiooncology I will share a broad perspective on cardio-onco-metabolism 🫀🦀⚡️🔜⬇️
Hosted by @CircRes, Susan Cheng, MD, MPH, shares her experience as a compendium editor. Drs. Cheng, Bairey Merz and @nataliebello9 recently worked on an anthology of 14 scientific articles that reviewed the past decade of women’s heart health. https://t.co/E15LtfC5Hl #AHA22
Need running shoes or a Tardis to get between 50+(!!!) parallel sessions…. discussing ECMO-CS trial (early ECMO vs deferred for shock - no difference in mortality, arrest or other MCS at 30-days)
#aha2022#LBCT
@SyedYNaqvi1 Favor MCS upfront. Control the hemodynamics, lower risk of upfront arrest with ballooning, and place PA Catheter after PCI to determine next steps with MCS. Much more controlled to place MCS upfront then trying to do in arresting patient with gear in coronaries.